Evidence map›Paper›PMID 32893934›Full record

ArticleThe EMBO journal2020

Fxr1 regulates sleep and synaptic homeostasis.

Jivan Khlghatyan, Alesya Evstratova, Lusine Bozoyan, Simon Chamberland, Dipashree Chatterjee, Aleksandra Marakhovskaia, Tiago Soares Silva, Katalin Toth, Valerie Mongrain, Jean-Martin Beaulieu

Abstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The why and how of sleep-dependent synaptic down-selection.Seminars in cell & developmental biology · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jivan KhlghatyanDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Alesya EvstratovaDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Lusine BozoyanDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Simon ChamberlandDepartment of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, Québec-City, QC, Canada.
Dipashree ChatterjeeDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Aleksandra MarakhovskaiaDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Tiago Soares SilvaDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Katalin TothDepartment of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Valerie MongrainDepartment of Neuroscience, Université de Montréal and Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS-NIM), Montreal, QC, Canada.
Jean-Martin BeaulieuDepartment of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-0446-7447

Funding

Canada Institutes of Health ResearchCanada Research Chairs (Chaires de recherche du Canada)Fonds de Recherche du Québec-Santé (FRQS)Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) PJT-148568
6 · The paper itself

Abstract

The fragile X autosomal homolog 1 (Fxr1) is regulated by lithium and has been GWAS-associated with schizophrenia and insomnia. Homeostatic regulation of synaptic strength is essential for the maintenance of brain functions and involves both cell-autonomous and system-level processes such as sleep. We examined the contribution of Fxr1 to cell-autonomous homeostatic synaptic scaling and neuronal responses to sleep loss, using a combination of gene overexpression and Crispr/Cas9-mediated somatic knockouts to modulate gene expression. Our findings indicate that Fxr1 is downregulated during both scaling and sleep deprivation via a glycogen synthase kinase 3 beta (GSK3β)-dependent mechanism. In both conditions, downregulation of Fxr1 is essential for the homeostatic modulation of surface AMPA receptors and synaptic strength. Preventing the downregulation of Fxr1 during sleep deprivation results in altered EEG signatures. Furthermore, sequencing of neuronal translatomes revealed the contribution of Fxr1 to changes induced by sleep deprivation. These findings uncover a role of Fxr1 as a shared signaling hub between cell-autonomous homeostatic plasticity and system-level responses to sleep loss, with potential implications for neuropsychiatric illnesses and treatments.

Indexed as

AnimalsBrainDisease Models, AnimalDown-RegulationGene Expression RegulationGene Knockout TechniquesHomeostasisMaleMiceMice, Inbred C57BLMice, KnockoutNeuronal PlasticityNeuronsReceptors, AMPARNA-Binding ProteinsSleepFxr1h protein, mouseReceptors, AMPARNA-Binding Proteinsallostatic loadFxr1scalingsleep deprivationsynaptic homeostasis

Identifiers

PMID32893934
PMCPMC7604579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.